Publikasjoner
Vitenskapelig artikkel
- Benjamin William Caulier; Sandy Joaquina; Pascal Francois Gelebart et al. (2024). CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. (ekstern lenke)
- Lovisa Wennström; Pernille Wendtland Edslev; Jonas Abrahamsson et al. (2016). Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the Nordic countries. (ekstern lenke)
- Dimitrios Kleftogiannis; Sonia Gavasso; Benedicte Sjo Tislevoll et al. (2024). Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry. (ekstern lenke)
- Dimitrios Kleftogiannis; Benedicte Sjo Tislevoll; Monica Hellesøy et al. (2022). Identifying predictors of survival in patients with leukemia using single-cell mass cytometry and machine learning. (ekstern lenke)
- Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2022). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (ekstern lenke)
- Mouldy Sioud; Anne Mobergslien; A. Boudabous et al. (2010). Evidence for the Involvement of Galectin-3 in Mesenchymal Stem Cell Suppression of Allogeneic T-Cell Proliferation. (ekstern lenke)
- Alejandro Garcia-Horton; Sunu L. Cyriac; Tobias Gedde-Dahl et al. (2022). Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. (ekstern lenke)
- Niek G. van der Maas; Jurjen Versluis; Kazem Nasserinejad et al. (2024). Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial. (ekstern lenke)
- Espen Østhagen Kvale; Yngvar Fløisand; Fridtjof Lund-Johansen et al. (2007). Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. (ekstern lenke)
- Alexandros Spyridonidis; Myriam Labopin; Bipin N. Savani et al. (2020). Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. (ekstern lenke)
- Mouldy Sioud; Yngvar Fløisand; Lise Forfang et al. (2006). Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+progenitor cells along the myeloid lineage. (ekstern lenke)
- Andreas Barratt-Due; Yngvar Fløisand; Hilde Elisabeth Lang et al. (2016). Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.. (ekstern lenke)
- Ekaterine Berishvili; Laurent Kaiser; Marie Cohen et al. (2020). Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy. (ekstern lenke)
- Dong Wang; Yngvar Fløisand; Camilla Victoria Myklebust et al. (2017). Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice. (ekstern lenke)
- Yngvar Fløisand; Lorentz Brinch; Thobias Gedde-Dahl et al. (2012). Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. (ekstern lenke)
- Mika Kontro; Anil Kumar; Muntasir Mamun Majumder et al. (2017). HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia. (ekstern lenke)
- Camilla Dao Vo; Anders Eivind Myhre; Ingerid Weum Abrahamsen et al. (2023). Allogen stamcelletransplantasjon hos voksne 2015–21. (ekstern lenke)
- Bjørn Christer Linder Grønvold; Maryan Mohamed Ali; Tor Åge Myklebust et al. (2024). Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors. (ekstern lenke)
- Yngvar Fløisand; Mark A. Schroeder; Patrice Chevallier et al. (2021). A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease. (ekstern lenke)
- Yngvar Fløisand; Mats Remberger; Iris Bigalke et al. (2023). WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy. (ekstern lenke)
- Mouldy Sioud; Phuong Westby; Vlada Vasovic et al. (2018). Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies. (ekstern lenke)
- Maryan Mohamed Ali; Bjørn Christer Linder Grønvold; Mats Remberger et al. (2021). Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival. (ekstern lenke)
- Tatsunori Goto; Hiroshi Okamura; Takashi Ikeda et al. (2025). Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study. (ekstern lenke)
- Bob Löwenberg; Thomas Pabst; Johan Maertens et al. (2021). Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial. (ekstern lenke)
- S. Cesaro; M. Pillon; G. Tridello et al. (2013). Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation. (ekstern lenke)
- Ayman Saad; Lawrence Lamb; Tao Wang et al. (2019). Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. (ekstern lenke)
- Amilton Moreira Fernandes; Sarah Herlofsen; Tommy Aleksander Karlsen et al. (2013). Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage. (ekstern lenke)
- Sara Bremer; Yngvar Fløisand; Lorentz Brinch et al. (2015). Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome after Myeloablative Conditioning. (ekstern lenke)
- O. Ringdén; M. Labopin; B Sadeghi et al. (2017). What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?. (ekstern lenke)
- Dag Torfoss; Tone Fladhagen; Harald Holte et al. (2016). Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. (ekstern lenke)
- Ana M T Quiles-Jiménez; Ida Gregersen; Filip Segers et al. (2021). DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development. (ekstern lenke)
- Tim Grob; Mathijs A. Sanders; Christian M. Vonk et al. (2023). Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia. (ekstern lenke)
- Aram Nikolai Andersen; Andrea M Brodersen; Pilar Ayuda Duran et al. (2023). Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling. (ekstern lenke)
- Silje Fjellgård Jørgensen; Jochen Buechner; Anders Eivind Myhre et al. (2021). A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT. (ekstern lenke)
- Tommy Aleksander Karlsen; Peyman Mirtaheri; Aboulghassem Shahdafar et al. (2011). Effect of Three-Dimensional Culture and Incubator Gas Concentration on Phenotype and Differentiation Capability of Human Mesenchymal Stem Cells. (ekstern lenke)
- Dagim Shiferaw Tadele; Joseph Robertson; Richard Crispin et al. (2020). A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation. (ekstern lenke)
- Anub Mathew Thomas; Alexandra Gerogianni; Martin Berner McAdam et al. (2019). Complement component C5 and TLR molecule CD14 mediate heme-induced thromboinflammation in human blood. (ekstern lenke)
- Are Martin Holm; GC Riise; L. Hansson et al. (2013). Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. (ekstern lenke)
- ANDRES SERVER; Núria Bargalló; Yngvar Fløisand et al. (2017). Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.. (ekstern lenke)
- Magnus Andreas Rognlien Husøy; Lorentz Brinch; Geir Erland Tjønnfjord et al. (2014). Allogen stamcelletransplantasjon hos voksne 1985-2012. (ekstern lenke)
- Yngvar Fløisand; Vladimir Lj. Lazarević; Johan Maertens et al. (2018). Safety and effectiveness of vedolizumab in patients with steroid-refractory gastrointestinal acute graft-versus-host disease: A retrospective record review. (ekstern lenke)
- Yngvar Fløisand; Knut Erik Aslaksen Lundin; Vladimir Lazarevic et al. (2016). Targeting integrin α4β7 in steroid-refractory intestinal graft-versus-host disease. (ekstern lenke)
- Mats Remberger; Geir Erland Tjønnfjord; Ingerid Weum Abrahamsen et al. (2021). Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG. (ekstern lenke)
- Jon-Magnus Tangen; Yngvar Fløisand; Einar Haukås et al. (2010). Overlevelse hos voksne med akutt lymfoblastisk leukemi :. (ekstern lenke)
- Mouldy Sioud; Solveig Pettersen; Ieva Ailte et al. (2019). Targeted killing of monocytes/macrophages and myeloid leukemia cells with pro-apoptotic peptides. (ekstern lenke)
- Ivetta Danylesko; Adomas Bukauskas; Martin Paulson et al. (2018). Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease. (ekstern lenke)
- Christian M. Vonk; Tim Grob; Melissa Rijken et al. (2025). Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML. (ekstern lenke)
- Mouldy Sioud; Anne Mobergslien; Abdellatif Boudabous et al. (2011). Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. (ekstern lenke)
- Yi-Bin Chen; Mohamad Mohty; Robert Zeiser et al. (2024). Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. (ekstern lenke)
- Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2023). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (ekstern lenke)
- Alice Gustavsen; Lillemor Skattum; Grete Bergseth et al. (2017). Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome. (ekstern lenke)
- Christian Vonk; Tim Grob; Mathijs Sanders et al. (2022). AML-234 Prognostic Value of FLT3-ITD Residual Disease in Acute Myeloid Leukemia. (ekstern lenke)
- Eli Taraldsrud; Børre Fevang; Pål Aukrust et al. (2014). Common variable immunodeficiency revisited: Normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. (ekstern lenke)
- Liv Ragnhild Høyvoll; Yngvar Fløisand; Hilde Elisabeth Lang et al. (2015). Hemophagocytic lymphohistiocytosis in leprosy. (ekstern lenke)
Konferanseabstrakt
- Dag Josefsen; Geir Hetland; Yngvar Fløisand et al. (2013). The use of Plerixafor in hard-to-mobilize lymphoma and multiple myeloma patients not only provide sufficient numbers of Pbpcs to proceed to high dose therapy, but also have a positive impact on survival. (ekstern lenke)
- Are Martin Holm; Gerdt C. Riise; Lars Hansson et al. (2012). Lung Transplantation for Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation. (ekstern lenke)
- Sara Bremer; Yngvar Fløisand; Lorentz Brinch et al. (2013). Pharmacogenetics of busulfan: significant association between GSTA1 genotype, busulfan pharmacokinetics and short term toxicity. (ekstern lenke)
- Lorentz Brinch; Yngvar Fløisand; Geir Erland Tjønnfjord et al. (2009). Allogeneic blood stem cell transplants for AML using the Bu4Cy2 regimen in AML: long term experience. (ekstern lenke)
- Dag Josefsen; Geir Hetland; Anne Kirsti Blystad et al. (2013). Successful use of plerixafor in hard to mobilize patients: following high dose therapy all patients developed fast and sustained engraftment with durable clinical responses. (ekstern lenke)
- Dag Heldal; Lorentz Brinch; Yngvar Fløisand et al. (2010). Long-term (>= 5 years) follow-up of a randomized study of allogeneic stem cell transplantation with stem cells from blood or bone marrow. (ekstern lenke)
- Dag Josefsen; Geir Hetland; Astrid Blystad et al. (2013). SUCCESSFUL USE OF PLERIXAFOR IN HARD TO MOBILIZE PATIENTS - FOLLOWING HIGH DOSE THERAPY ALL PATIENTS DEVELOPED FAST AND SUSTAINED ENGRAFTMENT WITH DURABLE CLINICAL RESPONSES. (ekstern lenke)
- Sara Bremer; Yngvar Fløisand; Stein Bergan (2013). Genotype Based Dosing May Improve Outcomes After Busulfan Conditioning. (ekstern lenke)
- Espen Østhagen Kvale; Yngvar Fløisand; Fridtjof Lund-Johansen et al. (2006). Plasmacytoid dendritic cells regulate recall responses by rapid induction of IL-10 in CD4+ memory T cells. (ekstern lenke)
Konferanseposter
- Dag Josefsen; Geir Hetland; Yngvar Fløisand et al. (2013). The use of Plerixafor in hard-to-mobilize lymphoma and multiple myeloma patients not only provide sufficient numbers of Pbpcs to proceed to high dose therapy, but also have a positive impact on survival. (ekstern lenke)
- Maria del Pilar Ayuda-Duran; B Zhang; L. Piechaczyck et al. (2017). a precision medicin platform for acute myeloid leukemia to help unraveling the molecular addictions of FLT3-ITD-driven AML. (ekstern lenke)
Leserbrev
- Are Martin Holm; Gerdt C. Riise; Lorentz Brinch et al. (2013). Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation: Unresolved Questions. (ekstern lenke)
- Phoi Phoi Diep; Hans Olav Melberg; Lorentz Brinch et al. (2018). Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway. (ekstern lenke)
- Yngvar Fløisand; Jan Delabie; Alexander Fosså et al. (2011). Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia. (ekstern lenke)
- Bjørn Christer Linder Grønvold; M.M. Ali; M. Remberger et al. (2020). HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation. (ekstern lenke)
Rettelse i tidsskrift
- Beibei Zhang; Maria del Pilar Ayuda-Duran; Laure Isabelle Piechaczyk et al. (2019). GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells. (ekstern lenke)
- Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2023). Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia (Nature Communications, (2023), 14, 1, (115), 10.1038/s41467-022-35624-4). (ekstern lenke)
- Alexandros Spyridonidis; Myriam Labopin; Bipin N. Savani et al. (2020). Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (Bone Marrow Transplantation, (2020), 55, 6, (1114-1125), 10.1038/s41409-020-0803-y). (ekstern lenke)